NIH Scientists Meeting in Secret, Won't Tell You Why
Published Date: 12/11/2025
Notice
Summary
The Center for Scientific Review is holding a closed virtual meeting on January 15, 2026, to review important grant applications. This meeting affects researchers seeking funding and keeps sensitive info private to protect ideas and personal details. No new costs or deadlines are announced, but the review helps decide who gets research money next.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
Closed NIH Grant Review Decides Awards
If you are a researcher applying for NIH grants, a virtual closed meeting of the Center for Scientific Review Special Emphasis Panel (Transition to Independence) will be held on January 15, 2026, from 10:00 a.m. to 6:00 p.m. to review and evaluate grant applications. The panel’s evaluations will help determine which applicants receive NIH research funding.
Grant Applicant Privacy Protected in Closed Review
The meeting will be closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, patentable material, and personal information in grant applications. The closed virtual format on January 15, 2026, is intended to keep applicants' ideas and personal details private.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20151, Notice of NIH Tribal Consultations and Listening Session
The NIH is inviting Tribal leaders and members to join two important meetings and a listening session during the National Congress of American Indians Annual Convention in October 2026. They’ll talk about new health research projects, renewing support for Tribal health centers, and shaping a new Tribal Data Sovereignty Policy. Tribes can also send their thoughts by November 20, 2026, helping shape future health programs and policies.
2026-19718, Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding two closed virtual meetings in October 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists and research teams applying for grants should note these dates as they impact funding decisions but don’t involve public attendance.
2026-19804, Submission for OMB Review; 30-Day Comment Request; Generic Clearance for NIH Citizen Science and Crowdsourcing Projects (Office of the Director)
The NIH is asking for approval to keep collecting info from citizen science and crowdsourcing projects, making it easier to gather public input on health research. This affects anyone involved in these projects and invites comments by October 28, 2026. No new costs or big changes, just a smooth way to keep the data flowing for better science!
2026-19719, Center for Scientific Review; Amended Notice of Meeting
The NIH’s Center for Scientific Review is shortening a key meeting from two days to just one day on October 13, 2026, keeping the same 9 a.m. to 6 p.m. hours. This change affects members of the Surgical Sciences and Bioengineering review group and means less time in the room but no public access. No money changes or delays are expected—just a quicker, tighter meeting!
2026-19706, Draft NIH Policy on Sharing Summary Level Study Results With Clinical Research Participants
The NIH wants to make it easier for people who join clinical studies to get simple summaries of the study results. This new policy aims to boost trust and teamwork between researchers and participants, helping science move faster and better. They’re asking for your thoughts by October 26, 2026, so get ready to share your ideas!
2026-19431, Government-Owned Inventions; Availability for Licensing
The government is offering a new invention for licensing that makes stem cell transplants safer and less harsh, especially for leukemia patients and older folks. This tech uses a special protein to prepare patients for transplants without the tough side effects of chemo and radiation. Companies can start licensing this preclinical innovation now to help bring better treatments to market faster.
Previous / Next Documents
Previous: 2025-22520, Senior Executive Service Performance Review Board; Membership
The EPA just announced the team that will review how well their top senior executives perform in 2025. This group of leaders will make sure the agency’s big bosses are doing a great job, helping keep the EPA running smoothly. No changes to pay or timing were mentioned, but this board’s work is key to keeping leadership accountable and effective.
Next: 2025-22522, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding a closed virtual meeting on January 8-9, 2026, to review cancer research grant applications. These meetings are private to protect sensitive information like trade secrets and personal details. Researchers applying for grants and the NIH are the main players, with no new costs or changes announced.